NEW YORK (GenomeWeb News) – The Alzheimer's Disease and Dementia Initiative at the New York Academy of Sciences and the Alzheimer's Drug Discovery Foundation and their corporate partners have awarded a $140,000 grant to fund researchers at Australia's Florey Institute of Neuroscience and Mental Health to validate a protein biomarker test for detecting Alzheimer's disease, NYAS said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.